Page last updated: 2024-10-30

losartan and Esophageal Stenosis

losartan has been researched along with Esophageal Stenosis in 1 studies

Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position

Esophageal Stenosis: A stricture of the ESOPHAGUS. Most are acquired but can be congenital.

Research Excerpts

ExcerptRelevanceReference
"To evaluate the efficacy of losartan in the prevention of restenosis after BD of esophageal stenosis in children with DEB."8.31Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa. ( Abaykhanov, R; Budkina, T; Dyakonova, E; Fisenko, A; Gusev, A; Lokhmatov, M; Murashkin, N; Oldakovskiy, V; Tupylenko, A; Yatzik, S, 2023)
"To evaluate the efficacy of losartan in the prevention of restenosis after BD of esophageal stenosis in children with DEB."4.31Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa. ( Abaykhanov, R; Budkina, T; Dyakonova, E; Fisenko, A; Gusev, A; Lokhmatov, M; Murashkin, N; Oldakovskiy, V; Tupylenko, A; Yatzik, S, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Oldakovskiy, V1
Murashkin, N1
Lokhmatov, M1
Gusev, A1
Tupylenko, A1
Budkina, T1
Yatzik, S1
Dyakonova, E1
Abaykhanov, R1
Fisenko, A1

Other Studies

1 other study available for losartan and Esophageal Stenosis

ArticleYear
Our experience of using Losartan for esophageal stenosis in children with dystrophic form of congenital epidermolysis bullosa.
    Journal of pediatric surgery, 2023, Volume: 58, Issue:4

    Topics: Adolescent; Child; Child, Preschool; Constriction, Pathologic; Epidermolysis Bullosa; Epidermolysis

2023